1 of 1
Story summary
- A study in Neurology found that a high-dose flu vaccine lowers Alzheimer's risk in seniors, with nearly a 55% reduction for the high-dose shot and 40% for the standard dose.
- The study enrolled over 121,000 seniors and showed stronger protection in women.
- Senior researcher Dr. Paul Schulz said many healthcare professionals are unaware of the high-dose option.
- Researchers say the study could not establish causation and call for further research.
